Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1994;84:811-815
© 1994 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KUTTEH, W. H.
Right arrow Articles by KUTTEH, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KUTTEH, W. H.
Right arrow Articles by KUTTEH, C. C.

Multiples of the Median: An Alternative Method for Reporting Antiphospholipid Antibodies in Women With Recurrent Pregnancy Loss

WILLIAM H. KUTTEH, MD, PhD, REBECCA WESTER, BS and CAROL C. KUTTEH, MD

From the Laboratory of Reproductive Immunology, Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas

Abstract

Objective: To determine whether using multiples of the median (MoM) is a useful method of standardization for reporting antiphospholipid antibody results.

Methods: Each antibody was measured by enzyme-linked immunosorbent assay using the Harris calibration set no. 2, with values recorded as phospholipid units and as MoM. The levels of antiphospholipid antibodies were compared in 100 nonpregnant women diagnosed with recurrent pregnancy loss (three or more spontaneous, consecutive losses) and 100 nonpregnant parous women with no history of reproductive problems (controls). Results were analyzed based on phospholipid units for immunoglobulin (Ig) G and IgM and were considered positive if phospholipid units were at least 20 or if MoM was at least 2.5. All lower values were considered negative.

Results: When results were calculated using at least 2.5 MoM as positive, none of the controls had positive levels. Overall, IgG anticardiolipin identified the largest number of women with elevated antiphospholipid antibodies. Immunoglobulin G antiphosphatidyl glycerol was more "selective" when elevated since none of the controls were positive by either analysis; however, only half of the subjects determined to be positive using anticardiolipin were identified.

Conclusion: The MoM method of reporting results may be more useful than phospholipid units for IgG or IgM.




This article has been cited by other articles:


Home page
Obstet GynecolHome page
R. D. Franklin and W. H. Kutteh
Effects of Unfractionated and Low Molecular Weight Heparin on Antiphospholipid Antibody Binding In Vitro
Obstet. Gynecol., March 1, 2003; 101(3): 455 - 462.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R.D. Franklin and W.H. Kutteh
Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population
Hum. Reprod., November 1, 2002; 17(11): 2981 - 2985.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Stern, G. Baker, and L.W. Chamley
Antiphospholipid antibodies and reproductive failure
Hum. Reprod., July 1, 2000; 15(7): 1649 - 1650.
[Full Text] [PDF]


Home page
Reproductive SciencesHome page
J. A. Hill
Immunotherapy for Recurrent Pregnancy Loss: "Standard of Care of Buyer Beware"
Reproductive Sciences, November 1, 1997; 4(6): 267 - 273.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American College of Obstetricians and Gynecologists.